Pear Therapeutics
About
What does Pear Therapeutics do?
Pear Therapeutics was a leader in developing and commercializing prescription digital therapeutics (PDTs), which are FDA-cleared software applications designed to treat serious diseases. Their approach integrated clinically validated software with pharmaceuticals to improve patient outcomes, provide clinician tools, and offer cost-effective solutions for payers. The company aimed to redefine care through the widespread use of these software-based therapeutics.
What is Pear Therapeutics's revenue?
StartupHub estimates Pear Therapeutics's annual revenue at $78.5M (range $29.9M to $272.3M, 29% confidence), based on comparable companies in the sector.
What is Pear Therapeutics's valuation?
StartupHub estimates Pear Therapeutics's effective valuation at $878.1M (range $614.7M to $1.1B, 26% confidence), based on comparable companies in the sector.
How much funding has Pear Therapeutics raised?
Pear Therapeutics has raised a total of $409M in funding. The most recent round on record is Post-IPO Equity.
Where is Pear Therapeutics headquartered?
Pear Therapeutics is headquartered in Boston, United States.
When was Pear Therapeutics founded?
Pear Therapeutics was founded in 2013.
What industry does Pear Therapeutics operate in?
Pear Therapeutics operates in HealthTech, MedTech, Biotech, Digital Therapeutics, Software as a Medical Device, Mental Health Tech.
What is Pear Therapeutics's current status?
Pear Therapeutics's current operating status is: Inactive.
No comments yet. Be the first to share your take.